T. Rowe Price Investment Management, Inc.

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1897612 BALTIMORE, MD

Position in ADPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,759,578

+$12,708,780 QoQ

Shares Held

919,278

+29288.7% QoQ

Ownership

0.574%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $6,542,644,824 across 13 Diagnostics & Research names. ADPT ranks #11 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVTY	Revvity, Inc.	22,198,422	$1,944,803,751
2	WAT	Waters Corp /De/	4,663,879	$1,388,903,166
3	A	Agilent Technologies, Inc.	8,992,649	$1,024,982,133
4	MTD	Mettler Toledo International Inc/	732,053	$923,265,243
5	DHR	Danaher Corp /De/	3,784,809	$717,599,786
6	NTRA	Natera, Inc.	1,130,820	$226,152,691
7	SHC	Sotera Health Co	9,125,621	$130,861,405
8	GH	Guardant Health, Inc.	755,707	$69,804,655

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,759,578	919,278	+29288.7%	Shares	Sole	2026-05-15
2025-12-31	$50,798	3,128	-99.7%	Shares	Sole	2026-02-19
2023-09-30	$5,834,704	1,070,588	0.0%	Shares	Sole	2023-11-14
2023-06-30	$7,183,645	1,070,588	-0.9%	Shares	Sole	2023-08-14
2023-03-31	$9,541,062	1,080,528	+61.7%	Shares	Sole	2023-05-15
2022-12-31	$5,105,063	668,202	-0.5%	Shares	Sole	2023-02-14
2022-09-30	$4,783,230	671,802	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.